The Development of Biocatalysis as a Tool for Drug Discovery

被引:14
作者
Schwarz, Jenny [1 ]
Rosenthal, Katrin [1 ]
Snajdrova, Radka [2 ]
Kittelmann, Matthias [3 ]
Lutz, Stephan [1 ]
机构
[1] TU Dortmund Univ, Chair Bioproc Engn, Emil Figge Str 66, D-44227 Dortmund, Germany
[2] Novartis Pharma AG, Global Discovery Chem, Lichtstr, CH-4056 Basel, Switzerland
[3] Novartis Pharma AG, Inst BioMed Res, Lichtstr, CH-4056 Basel, Switzerland
关键词
Biocatalysis; Chiral building blocks; Drug metabolites; Natural product modifications; Pharmacological activity; ENZYMATIC-SYNTHESIS; CHEMOENZYMATIC SYNTHESIS; ESCHERICHIA-COLI; ALDEHYDE OXIDASE; AMIDOHYDROLASE; RECOMBINANT; METABOLISM; ENZYMES; REGENERATION; PURIFICATION;
D O I
10.2533/chimia.2020.368
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Enzymes are versatile biocatalysts capable of performing selective reactions. The advantages of enzymes in comparison to classical chemistry including chemical catalysts are the generally milder process conditions and avoidance of harmful reactants. Their high selectivity and specificity are especially beneficial for the enzymatic synthesis of new products with potential applications in drug research. Therefore, in the past decades, the utilization of isolated enzymes or whole-cell biocatalysts has spread through a growing number of biotechnological industries. The applications comprise the production of chiral building blocks for the pharmaceutical and fine chemical industry, the enzymatic synthesis of drug metabolites for testing of toxicity, function, biological activity, degradation and the production of biocatalytically modified natural products, which all play a role in drug discovery. Especially Oreste Ghisalba's contributions, which paved the way for the industrial use of enzymes, will be considered in this review.
引用
收藏
页码:368 / 377
页数:10
相关论文
共 73 条
  • [1] Biocatalysis: A Pharma Perspective
    Adams, Joseph P.
    Brown, Murray J. B.
    Diaz-Rodriguez, Alba
    Lloyd, Richard C.
    Roiban, Gheorghe-Doru
    [J]. ADVANCED SYNTHESIS & CATALYSIS, 2019, 361 (11) : 2421 - 2432
  • [2] Purification and Mechanism of Human Aldehyde Oxidase Expressed in Escherichia coli
    Alfaro, Joshua F.
    Joswig-Jones, Carolyn A.
    Ouyang, Wenyun
    Nichols, Joseph
    Crouch, Gregory J.
    Jones, Jeffrey P.
    [J]. DRUG METABOLISM AND DISPOSITION, 2009, 37 (12) : 2393 - 2398
  • [3] Engineering enzymes for noncanonical amino acid synthesis
    Almhjell, Patrick J.
    Boville, Christina E.
    Arnold, Frances H.
    [J]. CHEMICAL SOCIETY REVIEWS, 2018, 47 (24) : 8980 - 8997
  • [4] Human xanthine oxidase recombinant in E. coli: A whole cell catalyst for preparative drug metabolite synthesis
    Antunes, Marcia Ferreira
    Eggimann, Fabian Kurt
    Kittelmann, Matthias
    Lutz, Stephan
    Hanlon, Steven P.
    Wirz, Beat
    Bachler, Thorsten
    Winkler, Margit
    [J]. JOURNAL OF BIOTECHNOLOGY, 2016, 235 : 3 - 10
  • [5] Bleif S., UNPUB
  • [6] Boville C., 2018, [No title captured], Patent No. [US 2018/0327793 A1, 20180327793]
  • [7] Dynamic knockdown of E-coli central metabolism for redirecting fluxes of primary metabolites
    Brockman, Irene M.
    Prather, Kristala L. J.
    [J]. METABOLIC ENGINEERING, 2015, 28 : 104 - 113
  • [8] Production, purification, and characterization of a highly enantioselective (S)-N-acetyl-1-phenylethylamine amidohydrolase from Rhodococcus equi Ac6
    Brunella, A
    Graf, M
    Kittelmann, M
    Laumen, K
    Ghisalba, O
    [J]. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 1997, 47 (05) : 515 - 520
  • [9] Buller A., 2016, [No title captured], Patent No. [US 2016/0298152 A1, 20160298152]
  • [10] Progress towards the easier use of P450 enzymes
    Chefson, Arnandine
    Auclair, Karine
    [J]. MOLECULAR BIOSYSTEMS, 2006, 2 (10) : 462 - 469